Sandoz, a Novartis division
Katharina is a biologist by training. She received a doctoral degree working on protein biochemistry and molecular tumour biology. Afterwards she decided to become a Medical Writer and joined Boehringer Ingelheim to start her regulatory medical writing career. In 2015, Katharina joined the Clinical Submission Management team of Sandoz, a Novartis division and continued working as a regulatory Medical Writer, mainly writing biosimilar submission documents. Katharina has been involved in document writing across various stages of clinical development and across various indications.